close up shot of a pink ribbon on a calendar

Latest Cancer Cure News 2023: Breakthroughs in Oncology

Latest Cancer Cure News 2023: The year 2023 has been a landmark year in the field of oncology, witnessing several groundbreaking advancements in cancer research and treatment. These developments offer new hope and expanded treatment options for patients battling various forms of cancer.

This article delves into some of the most significant breakthroughs that have emerged this year, marking a new era in the fight against this formidable disease.

Latest Cancer Cure News 2023: Breakthroughs in Oncology
Photo by Leeloo Thefirst on

Latest Cancer Cure News 2023: Breakthroughs in Oncology

Braftovi and Mektovi for Metastatic NSCLC

Latest Cancer Cure News 2023: One of the most notable approvals by the FDA this year was for Braftovi (encorafenib) in combination with Mektovi (binimetinib) for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC).

This approval was a result of the PHAROS trial, which demonstrated significant clinical benefits with a safety profile consistent with previous observations in melanoma treatments. This combination therapy represents a significant step forward in treating NSCLC, offering patients a new line of defense against this aggressive cancer type.

Trodelvy in Small Cell Lung Cancer

Latest Cancer Cure News 2023: Another breakthrough came with Trodelvy (sacituzumab govitecan-hziy), which showed promising results as a second-line treatment for patients with extensive-stage small cell lung cancer (ES-SCLC). The phase 2 trial of this drug is ongoing, with full results expected in early 2024.

This development is particularly significant as it provides a new treatment avenue for patients with ES-SCLC, a cancer type that has historically been challenging to treat.

Anamorelin for Lung Cancer Cachexia

Latest Cancer Cure News 2023: Anamorelin, in trials ANAM 17-20 and ANAM-17-21, showed effectiveness in improving weight gain in patients with non-small cell lung cancer (NSCLC) experiencing cachexia.

These findings, presented at the 2023 ESMO Annual Congress, are crucial as cachexia is a common and severe complication in cancer patients, often leading to a significant decline in quality of life and survival rates.

Jemperli Plus Chemotherapy in Advanced NSCLC

Latest Cancer Cure News 2023: The combination of Jemperli (dostarlimab-gxly) with chemotherapy has shown to be more effective than Keytruda (pembrolizumab) combined with chemotherapy in treating patients with treatment-naïve, nonsquamous NSCLC.

This combination therapy has demonstrated higher objective response rates and overall survival improvements, marking a significant advancement in the treatment of this cancer type.

Yale Scientists Expedite Cancer Research

Latest Cancer Cure News 2023: In a major development, scientists at Yale School of Medicine have been chosen by a new White House initiative to expedite cancer research. This initiative is part of a broader effort to accelerate the discovery of cancer cures and represents a significant investment in the future of cancer treatment.


The year 2023 has brought with it a wave of optimism in the field of cancer research and treatment. These breakthroughs, ranging from new drug approvals to innovative research initiatives, are reshaping the landscape of cancer care.

As we continue to make strides in understanding and combating this disease, the future looks increasingly hopeful for patients and their families. The fight against cancer is far from over, but the progress made in 2023 is a testament to the relentless pursuit of a cure and the resilience of the human spirit in the face of adversity.

Latest Pharma News from Witfire